What is NDC 0054-0140?

0054-0140 is the product NDC for Acarbose, Acarbose 25 mg/1 tablet, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0054. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Acarbose?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Acarbose NDC 0054-0140 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0054-0140Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00054-0140Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0054-0140-25	00054014025	100 TABLET in 1 BOTTLE (0054-0140-25)Marketed from May 7, 2008

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acarbose
Generic name (nonproprietary): acarbose
Active ingredients: Acarbose — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0054
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078470
Marketing start: May 7, 2008
Listing expires: Dec 31, 2026
Other FDA classes: alpha Glucosidase Inhibitors (Mechanism)
Identifiers: Product ID 0054-0140_2d7f6918-65c3-4db3-b775-b74e1e637ceaSPL ID 2d7f6918-65c3-4db3-b775-b74e1e637ceaSPL set ID 352dd336-d3f9-4ac5-a000-91d3aef7aca3RxCUI 199149, 199150, 200132UNII T58MSI464GUPC 0300540140250
Pharmacologic class: alpha-Glucosidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400054014025 followed by a unit qualifier and the quantity

Package 00054-0140-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 19, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Acarbose Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0054-0140

What is NDC 0054-0140?: 0054-0140 is the product NDC for Acarbose, Acarbose 25 mg/1 tablet, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Acarbose.
What is the active ingredient?: Acarbose.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0054. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Acarbose?: 16 other product NDCs are listed under this name. See all Acarbose NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Acarbose NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Acarbose	Acarbose 25 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-147	23155-0147-0123155-0147-0523155-0147-10
Acarbose	Acarbose 50 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-148	23155-0148-0123155-0148-0523155-0148-10
Acarbose	Acarbose 100 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-149	23155-0149-0123155-0149-0523155-0149-10
Acarbose	Acarbose 25 mg/1	TabletOral	Chartwell RX, LLC	62135-453	62135-0453-90
Acarbose	Acarbose 50 mg/1	TabletOral	Chartwell RX, LLC	62135-454	62135-0454-90
Acarbose	Acarbose 100 mg/1	TabletOral	Chartwell RX, LLC	62135-455	62135-0455-90
Acarbose	Acarbose 50 mg/1	TabletOral	Bryant Ranch Prepack	71335-9725	71335-9725-0171335-9725-0271335-9725-03
Acarbose	Acarbose 50 mg/1	TabletOral	Bryant Ranch Prepack	63629-5698	63629-5698-0163629-5698-0263629-5698-03
Acarbose	Acarbose 50 mg/1	TabletOral	Strides Pharma Science Limited	64380-759	64380-0759-06
Acarbose	Acarbose 100 mg/1	TabletOral	Strides Pharma Science Limited	64380-760	64380-0760-06

All 17 Acarbose NDCs

Other NDCs under ANDA 078470

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078470
Product	Strength	Form · route	Labeler	Product NDC
Acarbose	Acarbose 50 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0141
Acarbose	Acarbose 100 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0142
Acarbose	Acarbose 25 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-131
Acarbose	Acarbose 50 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-132
Acarbose	Acarbose 100 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-133